Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment-Implications for Therapy

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• The tumor microenvironment (TME) comprises diverse cellular and non-cellular components.
• The TME significantly impacts cancer cell proliferation, metastasis, and response to therapy.
• Current cancer treatments aim to target various aspects of the TME.

Purpose of the Study:

• To provide a comprehensive review of the TME's influence on cancer therapy sensitivity.
• To discuss the role of the TME in modulating the efficacy of diverse anti-cancer strategies.
• To cover the impact of the TME across all solid tumor types.

Main Methods:

• Literature review of existing research on the tumor microenvironment and cancer therapies.
• Synthesis of information on various therapeutic strategies targeting the TME.
• Analysis of the TME's role in modulating treatment response in solid tumors.

Main Results:

• The TME critically affects the efficacy of chemotherapy, radiotherapy, and immunotherapy.
• Targeting cancer-associated fibroblasts (CAFs) and utilizing oncolytic viruses (OVs) are key TME-focused strategies.
• The TME's composition dictates sensitivity to novel therapies like cold atmospheric plasma and nanovaccines.

Conclusions:

• The TME is a pivotal determinant of therapeutic outcomes in solid tumors.
• Targeting the complex TME is essential for improving cancer treatment efficacy.
• Further research into TME modulation holds promise for advancing cancer therapy.